Search Results 51-60 of 3449 for Solid
... solid tumors. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
Histologically or cytologically confirmed recurrent solid tumors. 1. Cohort 1a: any extracranial solid tumor (may include EC, ovarian clear cell, or ovarian ...
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery ... solid tumors or ...
Study of Sexuality and Quality of Life in Solid Organ Transplant Recipients · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
About this study. A Phase 1a/1b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY314 as a Single Agent and ...
About this study. A Phase 1, first-in-human study of EP31670, a dual BET and CBP/p300 inhibitor in patients with targeted advanced solid tumors and ...
The purpose of this study is to test the safety and side effects of a drug called XMT-1660. Participation eligibility. Participant eligibility includes age, ...
But they sometimes have solid parts that are cancer. Multinodular goiter. A goiter is an enlarged thyroid gland. Lack of iodine in the diet or a thyroid problem ...
Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...
... solid tumors using the standard cohort 3+3 design (5 dose levels) followed by an expansion cohort of an additional 6 patients. Patients are dosed Days 1, 8 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.